Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
about
The promise of neuroprotective agents in Parkinson's diseaseAn overview of clinical pharmacology of IbuprofenIbuprofen for Alzheimer's diseaseUse of ibuprofen and risk of Parkinson diseaseInsights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based TherapiesThe Role of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in the Treatment of Patients With Hepatic Disease: A Review ArticleNonsteroidal anti-inflammatory drugs and risk of Parkinson's diseaseFlavonoids: modulators of brain function?Acetaminophen induces apoptosis in rat cortical neuronsAquaporin-4 inhibition mediates piroxicam-induced neuroprotection against focal cerebral ischemia/reperfusion injury in rodentsA microfluidic phenotype analysis system reveals function of sensory and dopaminergic neuron signaling in C. elegans electrotactic swimming behavior.Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseasesIs pharmacological prevention of Alzheimer's a realistic goal?Non-steroidal anti-inflammatory drug use and the risk of Parkinson's disease.Human gut microbiota: the links with dementia developmentNonsteroidal anti-inflammatory drugs in Parkinson's disease: possible involvement of quinone formation.The neuroprotective potential of flavonoids: a multiplicity of effectsDual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy.Effects of Oxidative Stress and Testosterone on Pro-Inflammatory Signaling in a Female Rat Dopaminergic Neuronal Cell LinePPAR Regulation of Inflammatory Signaling in CNS Diseases.Glial-mediated inflammation underlying parkinsonism.Acetaminophen attenuates lipopolysaccharide-induced cognitive impairment through antioxidant activity.Beyond antioxidants: the cellular and molecular interactions of flavonoids and how these underpin their actions on the brain.The impact of fruit flavonoids on memory and cognition.Preconditioning as a potential strategy for the prevention of Parkinson's disease.Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches.A research update on the potential roles of aquaporin 4 in neuroinflammation.Flavonoids and brain health: multiple effects underpinned by common mechanisms.Selective cyclooxygenase-2 inhibitor compound 11b improves haloperidol-induced catatonia by enhancing the striatum dopaminergic neurotransmission.The selective cyclooxygenase-2 inhibitor, the compound 11b improves haloperidol induced catatonia by enhancing the striatum dopaminergic neurotransmission.Are NSAIDs useful to treat Alzheimer's disease or mild cognitive impairment?Antidepressant and antioxidative effect of Ibuprofen in the rotenone model of Parkinson's disease.Effects of non-steroidal antiinflammatory drugs on D-serine-induced oxidative stress in vitro.Ibuprofen abates cypermethrin-induced expression of pro-inflammatory mediators and mitogen-activated protein kinases and averts the nigrostriatal dopaminergic neurodegeneration.Electron attachment to antipyretics: Possible implications of their metabolic pathwaysNeuroprotective Effect of Nortriptyline in Overt Hepatic Encephalopathy Through Attenuation of Mitochondrial Dysfunction
P2860
Q21129436-AD71ED22-F06D-40F0-8574-A27E9ED39F21Q23724883-41A9626D-F917-4828-8C76-90F23F77B601Q24248782-540E20AA-1B16-445B-B1F1-5802D24CBAD3Q24594751-C25A5C72-B79C-4B52-B7AA-85BCF8F34382Q26795984-E222910D-7451-44D4-8FF7-D809DB6B6B82Q28075382-89F4E92D-9038-4AD8-917B-54300998DF57Q28195845-64B839C0-31E3-44DA-9670-30F26F42C7D8Q28281453-A5E83778-FED8-42A3-A77E-AA36D69382B0Q28476494-71173134-BDC6-459C-92EF-18DDA870CA90Q28536674-64469E04-60E9-44D9-B8B0-A3FBC1F135B0Q30541240-AC4D1E64-1B2F-4F04-A72F-B1670196B8B5Q34071942-994E0782-8437-4B59-8B8E-FE04D5CBBE99Q34588663-BB18700E-99A4-4B6A-B5EB-2E7DF27F0A9DQ34985170-AA4C6C20-DB47-4FBB-941D-DDD73C52FF41Q36198753-2092A387-4B7D-4FF8-9FE1-2F7BE88F261BQ36607332-79DF5849-433B-4F71-99C3-ECBD4DF7FCA4Q36993769-205AE043-BA43-4E73-9470-5E1E99F1FB7EQ37010500-8A41D243-7472-4F66-AAD6-F11C63EC8995Q37057444-5660D7DC-51C4-44E6-BDBC-A519140BA7EDQ37231755-882A1E1D-B863-4477-8D3F-E776B70F1B4EQ37287778-034D993C-001D-46A0-8DA0-B9412B3C10CFQ37597304-A3364677-BC73-45DF-9AB6-5993838983FEQ37693243-EB0EA827-A8BC-4587-A6FF-1F0FC8566242Q37801021-9B536626-C2A2-4A14-BC7F-D64AC6F415A9Q38201685-FA2CDF53-3622-490B-AF75-3DBC77CD8B10Q38209311-808810F7-0F81-48E6-98A5-4BB6DF3CDCD3Q38563837-F137435D-0B69-4BC4-A1CA-57FDB7D7A5D7Q41890595-2A596BB9-42D4-4764-B78B-391A89E22E6AQ41988837-33701A48-E2DC-434E-9989-A098AEB747C1Q42212454-5FE0B204-26CC-4E4A-8B1B-9C55CBAAB90BQ42659546-F876ADAE-BD13-4A51-A38D-E5573C238750Q48311920-682E78B7-47B0-4867-9A44-3B2208A82067Q48578036-F00482AB-51ED-41D8-B24B-7AACAA449F49Q49159748-6C389428-DCA6-4F41-8828-60BE3877864EQ57520062-381C8907-7150-45FF-9E59-3AB1947A43CDQ59136651-5A5A4497-2BEA-4766-AE76-98BBAC23985A
P2860
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
@ast
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
@en
type
label
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
@ast
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
@en
prefLabel
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
@ast
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
@en
P2093
P1433
P1476
Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro.
@en
P2093
P304
P356
10.1016/S0304-3940(00)01294-5
P407
P577
2000-08-01T00:00:00Z